Monoamine Oxidase Inhibitors

"Monoamine Oxidase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)

Descriptor ID	D008996
MeSH Number(s)	D27.505.519.389.616
Concept/Terms	Monoamine Oxidase Inhibitors Monoamine Oxidase Inhibitors Inhibitors, Monoamine Oxidase Monoamine Oxidase Inhibitor Inhibitor, Monoamine Oxidase MAO Inhibitors Inhibitors, MAO RIMA (Reversible Inhibitor of Monoamine Oxidase A) RIMA (Reversible Inhibitor of Monoamine Oxidase A) Reversible Inhibitors of Monoamine Oxidase Reversible Inhibitors of Monoamine Oxidase Reversible Inhibitor of Monoamine Oxidase

Below are MeSH descriptors whose meaning is more general than "Monoamine Oxidase Inhibitors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Enzyme Inhibitors [D27.505.519.389]
Monoamine Oxidase Inhibitors [D27.505.519.389.616]

Below are MeSH descriptors whose meaning is related to "Monoamine Oxidase Inhibitors".

Below are MeSH descriptors whose meaning is more specific than "Monoamine Oxidase Inhibitors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Monoamine Oxidase Inhibitors" by people in this website by year, and whether "Monoamine Oxidase Inhibitors" was a major or minor topic of these publications.

Bar chart showing 8 publications over 7 distinct years, with a maximum of 2 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
1998	1	0	1
2001	0	1	1
2003	0	1	1
2008	1	1	2
2014	0	1	1
2022	1	0	1

Below are the most recent publications written about "Monoamine Oxidase Inhibitors" by people in Profiles.

Van den Eynde V, Abdelmoemin WR, Abraham MM, Amsterdam JD, Anderson IM, Andrade C, Baker GB, Beekman ATF, Berk M, Birkenh?ger TK, Blackwell BB, Blier P, Blom MBJ, Bodkin AJ, Cattaneo CI, Dantz B, Davidson J, Dunlop BW, Est?vez RF, Feinberg SS, Finberg JPM, Fochtmann LJ, Gotlib D, Holt A, Insel TR, Larsen JK, Mago R, Menkes DB, Meyer JM, Nutt DJ, Parker G, Rego MD, Richelson E, Ruh? HG, S?iz-Ruiz J, Stahl SM, Steele T, Thase ME, Ulrich S, van Balkom AJLM, Vieta E, Whyte I, Young AH, Gillman PK. The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. CNS Spectr. 2023 08; 28(4):427-440.

View in: PubMed
Ferrari-Amorotti G, Chiodoni C, Shen F, Cattelani S, Soliera AR, Manzotti G, Grisendi G, Dominici M, Rivasi F, Colombo MP, Fatatis A, Calabretta B. Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity. Neoplasia. 2014 Dec; 16(12):1047-58.

View in: PubMed
Sun-Edelstein C, Tepper SJ, Shapiro RE. Drug-induced serotonin syndrome: a review. Expert Opin Drug Saf. 2008 Sep; 7(5):587-96.

View in: PubMed
Mago R, Mahajan R, Thase ME. Medically serious adverse effects of newer antidepressants. Curr Psychiatry Rep. 2008 Jun; 10(3):249-57.

View in: PubMed
Tepper S, Allen C, Sanders D, Greene A, Boccuzzi S. Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients. Headache. 2003 Jan; 43(1):44-8.

View in: PubMed
Silberstein SD. Migraine: preventive treatment. Curr Med Res Opin. 2001; 17 Suppl 1:s87-93.

View in: PubMed
Ellison JM. Antidepressant-induced sexual dysfunction: review, classification, and suggestions for treatment. Harv Rev Psychiatry. 1998 Nov-Dec; 6(4):177-89.

View in: PubMed
Zhang W, Johnson BR, Bjornsson TD. Pharmacologic inhibition of transglutaminase-induced cross-linking of Alzheimer's amyloid beta-peptide. Life Sci. 1997; 60(25):2323-32.

View in: PubMed
Erich JL, Shih RD, O'Connor RE. "Ping-pong" gaze in severe monoamine oxidase inhibitor toxicity. J Emerg Med. 1995 Sep-Oct; 13(5):653-5.

View in: PubMed
Ellison JM, Adler DA. Psychopharmacologic approaches to borderline syndromes. Compr Psychiatry. 1984 May-Jun; 25(3):255-62.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement